Skip to Main content Skip to Navigation
New interface
Journal articles

New strategies for ventricular tachycardia and ventricular fibrillation ablation

Abstract : Patients with ventricular tachycardia (VT) and ventricular fibrillation (VF) and no reversible cause are difficult to treat. While implantable defibrillators prolong survival, many patients remain symptomatic due to device shocks and syncope. To address this, there have been recent advances in the catheter ablation of VT and VF. For example, non-invasive imaging has improved arrhythmia substrate characterisation, 3D catheter navigation tools have facilitated mapping of arrhythmia and substrate and ablation catheters have advanced in their ability to deliver effective lesions. However, the long-term success rates of ablation for VT and VF remain modest, with nearly half of treated patients developing recurrence within 2-3 years, and this drives the ongoing innovation in the field. This review focuses on the challenges particular to ablation of life-threatening ventricular arrhythmia, and the strategies that have been recently developed to improve procedural efficacy. Patient sub-groups that illustrate the use of new strategies are described.
Document type :
Journal articles
Complete list of metadata
Contributor : Jean-Marc SELLAL Connect in order to contact the contributor
Submitted on : Sunday, May 23, 2021 - 8:37:55 PM
Last modification on : Saturday, May 29, 2021 - 3:31:01 AM




Darren Hooks, Benjamin Berte, Seigo Yamashita, Saagar Mahida, Jean-Marc Sellal, et al.. New strategies for ventricular tachycardia and ventricular fibrillation ablation. Expert Review of Cardiovascular Therapy, 2015, 13 (3), pp.263-276. ⟨10.1586/14779072.2015.1009039⟩. ⟨hal-03233118⟩



Record views